Skip to main content
Premium Trial:

Request an Annual Quote

Myriad Genetics Wins $14.2M NIH Contract to Analyze Host-Pathogen Protein Interactions

NEW YORK, July 8 (GenomeWeb News) - Myriad Genetics has won $14.2 million from the National Institute of Allergy and Infectious Diseases to analyze pathogen-host protein interactions using high-throughput proteomics.

 

Under the five-year contract, Salt Lake City-based Myriad will use its yeast two-hybrid technology, bioinformatics, and DNA sequencing to conduct proteome-wide analyses of protein interactions between humans and selected pathogens. Myriad also plans to validate these interactions by other methods, such as microbial gene knockout and siRNA.

 

Myriad will have the rights to commercialize diagnostic and therapeutic targets discovered in the project. All protein interaction and validation data will be made publicly available through the Proteomics Research Program Administrative Center.

The Scan

More Boosters for US

Following US Food and Drug Administration authorization, the Centers for Disease Control and Prevention has endorsed booster doses of the Moderna and Johnson & Johnson SARS-CoV-2 vaccines, the Washington Post writes.

From a Pig

A genetically modified pig kidney was transplanted into a human without triggering an immune response, Reuters reports.

For Privacy's Sake

Wired reports that more US states are passing genetic privacy laws.

Science Paper on How Poaching Drove Evolution in African Elephants

In Science this week: poaching has led to the rapid evolution of tuskless African elephants.